clopidogrel has been researched along with Coronary Occlusion in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 14 (70.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrabba, N; De Gregorio, MG; Giusti, B; Gori, AM; Marchionni, N; Marcucci, R; Migliorini, A; Paniccia, R; Valenti, R; Vergara, R | 1 |
| Cui, CS; Hou, AJ; Luan, B; Luo, DF; Meng, QK; Tao, J; Wang, CF; Wang, Y; Zhang, XJ; Zhao, HW; Zhu, Y | 1 |
| Chen, Y; Wang, B; Wang, W; Wei, S | 1 |
| Shi, W; Yan, L; Yang, J; Yu, M | 1 |
| Bhatt, DL; Day, JRS; Gibson, CM; Hamm, CW; Mahaffey, KW; Parker, WA; Prats, J; Price, MJ; Steg, PG; Stone, GW; Storey, RF; White, HD | 1 |
| Alcalde Martinez, V; Brugaletta, S; Caballero, J; Cequier, A; Correa Vilches, C; Gomez-Hospital, JA; Gomez-Lara, J; Jimenez Fernandez, M; Joyera, M; Molina Navarro, E; Ñato, M; Ortega-Paz, L; Romaguera, R; Sabate, M; Teruel, L | 1 |
| Angiolillo, DJ; Brugaletta, S; Caballero, J; Cequier, A; Fernandez, MJ; Gomez-Hospital, JA; Gomez-Lara, J; Joyera, M; Martinez, VA; Ñato, M; Navarro, EM; Ortega-Paz, L; Romaguera, R; Sabate, M; Teruel, L; Vilches, CC | 1 |
| Cavallari, LH; Cicci, JD; Clarke, M; Klein, MD; Lee, CR; Madan, S; Martin, J; Rossi, JS; Sriramoju, VB; Stouffer, GA; Weck, KE; Williams, AK | 1 |
| McKinnon, RA; Rowland, A; Sorich, MJ; Wiese, MD | 1 |
| Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Jang, WJ; Kim, BS; Kim, WS; Lee, SH; Lee, YT; Song, YB; Yang, JH | 1 |
| Abbate, R; Antoniucci, D; Cantini, G; Carrabba, N; Cerisano, G; Comito, V; Gensini, GF; Gori, AM; Marcucci, R; Marrani, M; Migliorini, A; Parodi, G; Valenti, R; Vergara, R | 1 |
| Al-Bustami, M; Ong, PJ; Shaukat, A | 1 |
| Cho, EJ; Her, SH; Jang, SW; Kim, DB; Kim, JH; Kwon, BJ; Park, CS; Park, HJ; Park, MW; Rho, TH; Shin, D | 1 |
| Dixon, SR; Grines, CL; O'Neill, WW | 1 |
| Barison, A; Bellini, F; Capozza, PF; de Carlo, M; Lunardini, A; Petronio, AS | 1 |
| Alvarez-Contreras, L; Brugaletta, S; Cola, C; García Picart, J; Martí, V; Martín-Yuste, V; Masotti, M; Sabaté, M | 1 |
| Ajani, AE; Andrianopoulos, N; Brennan, AL; Clark, DJ; Duffy, SJ; Loane, P; Reid, CM; Yan, BP | 1 |
| Eno, S; Hondo, T; Iwamoto, A; Kimura, M; Matsuda, K; Matsumura, H | 1 |
| Antignan, A; De Amicis, V; Di Tommaso, L; Mannacio, VA; Vosa, C | 1 |
| Elefteriades, JA; Meier, P | 1 |
3 review(s) available for clopidogrel and Coronary Occlusion
| Article | Year |
|---|---|
Ethnic variance on long term clinical outcomes of concomitant use of proton pump inhibitors and clopidogrel in patients with stent implantation: A PRISMA-complaint systematic review with meta-analysis.
Topics: Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Occlusion; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Racial Groups; Stents; Treatment Outcome | 2021 |
CYP2C19 genotype has a greater effect on adverse cardiovascular outcomes following percutaneous coronary intervention and in Asian populations treated with clopidogrel: a meta-analysis.
Topics: Alleles; Asian People; Clopidogrel; Coronary Occlusion; Cytochrome P-450 CYP2C19; Databases, Factual; Genotype; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk; Stents; Thrombosis; Ticlopidine | 2014 |
The year in interventional cardiology.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Occlusion; Coronary Restenosis; Drug-Eluting Stents; Foramen Ovale, Patent; Hospital Mortality; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Radiology, Interventional; Thiophenes; Thrombolytic Therapy; Ticagrelor; Ticlopidine; Treatment Outcome | 2010 |
4 trial(s) available for clopidogrel and Coronary Occlusion
| Article | Year |
|---|---|
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study.
Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Occlusion; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Percutaneous Coronary Intervention; Receptors, Purinergic P2Y12; Survival Analysis; Ticlopidine; Treatment Outcome; Withholding Treatment | 2017 |
TIcaGrEloR and Absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization (TIGER-BVS trial): Rationale and study design.
Topics: Absorbable Implants; Chronic Disease; Clopidogrel; Coronary Angiography; Coronary Circulation; Coronary Occlusion; Female; Humans; Male; Multicenter Studies as Topic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Randomized Controlled Trials as Topic; Recovery of Function; Ticagrelor; Time Factors; Treatment Outcome | 2018 |
Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: A randomized clinical trial.
Topics: Clopidogrel; Coronary Circulation; Coronary Occlusion; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Ticagrelor; Treatment Outcome | 2018 |
Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass, Off-Pump; Coronary Occlusion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome | 2012 |
13 other study(ies) available for clopidogrel and Coronary Occlusion
| Article | Year |
|---|---|
Clinical Implications of "Tailored" Antiplatelet Therapy in Patients With Chronic Total Occlusion.
Topics: Aged; Clopidogrel; Coronary Occlusion; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Registries; Survival Rate; Ticagrelor | 2020 |
Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study.
Topics: Aged; Asian People; China; Chronic Disease; Clopidogrel; Coronary Occlusion; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome | 2020 |
Late Stent Thrombosis After Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis.
Topics: Acute Disease; Adult; Aftercare; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Cytochrome P-450 CYP2C19; Dual Anti-Platelet Therapy; Female; Fibrinolytic Agents; Humans; Integrin alpha2; Mutation; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Stents; Thrombectomy; Thrombosis; Ticagrelor; Tirofiban; Treatment Outcome | 2021 |
Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting.
Topics: Aged; Clopidogrel; Coronary Occlusion; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Precision Medicine; Prospective Studies; Ticlopidine; Treatment Outcome | 2020 |
Clinical outcomes of multiple chronic total occlusions in coronary arteries according to three therapeutic strategies: Bypass surgery, percutaneous intervention and medication.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Occlusion; Coronary Vessels; Death; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2015 |
Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus.
Topics: Aged; Blood Platelets; Chronic Disease; Clopidogrel; Coronary Occlusion; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Incidence; Italy; Male; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prognosis; Retrospective Studies; Survival Rate; Ticlopidine; Time Factors | 2015 |
Chronic total occlusion--use of a 5 French guiding catheter in a 6 French guiding catheter.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Occlusion; Coronary Restenosis; Coronary Vessels; Humans; Male; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2008 |
Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occlusion; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Sirolimus; Tetrazoles; Ticlopidine; Ventricular Fibrillation | 2010 |
Recurrent episodes of very late stent thrombosis in a patient with aspirin hypersensitivity, stent fracture and malapposition.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Occlusion; Coronary Thrombosis; Drug Hypersensitivity; Drug-Eluting Stents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Failure; Recurrence; Ticlopidine; Time Factors; Tomography, Optical Coherence | 2011 |
[Usefulness of the Tornus® catheter in nondilatable coronary chronic total occlusion].
Topics: Aged; Cardiac Catheterization; Catheterization; Catheters; Clopidogrel; Coronary Angiography; Coronary Occlusion; Female; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Failure | 2011 |
Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne Interventional Group registry.
Topics: Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Australia; Clopidogrel; Comorbidity; Coronary Occlusion; Coronary Restenosis; Coronary Thrombosis; Diabetes Mellitus; Drug Utilization; Drug-Eluting Stents; Emergencies; Female; Hemorrhage; Hospital Mortality; Humans; Logistic Models; Male; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Renal Insufficiency; Shock, Cardiogenic; Ticlopidine | 2011 |
A case of acute coronary artery occlusion associated with very rapid onset heparin-induced thrombosis without thrombocytopenia.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Aspirin; Autoantibodies; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occlusion; Drug Therapy, Combination; Female; Heart Failure; Heparin; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Stents; Sulfonamides; Tetrazoles; Thrombosis; Ticlopidine; Time Factors | 2012 |
Clopidogrel and cardiac surgery: enemy or friend?
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Occlusion; Female; Humans; Male; Platelet Aggregation; Ticlopidine | 2012 |